GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Net Income Including Noncontrolling Interests

Clal Biotechnology Industries (XTAE:CBI) Net Income Including Noncontrolling Interests : ₪-75.07 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Clal Biotechnology Industries's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2024 was ₪-34.58 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 was ₪-75.07 Mil.


Clal Biotechnology Industries Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Clal Biotechnology Industries's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Net Income Including Noncontrolling Interests Chart

Clal Biotechnology Industries Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.84 -128.21 -95.43 -28.09 -75.07

Clal Biotechnology Industries Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.95 3.32 -31.41 -40.50 -34.58

Clal Biotechnology Industries Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-75.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clal Biotechnology Industries Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Clal Biotechnology Industries Business Description

Industry
Traded in Other Exchanges
N/A
Address
Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.

Clal Biotechnology Industries Headlines

From GuruFocus

McDermott Announces Ethylene Furnace Award in Indonesia

By PRNewswire PRNewswire 01-24-2019

Chairman, CEO, CFO Purchase Shares in McDermott

By PRNewswire PRNewswire 11-07-2018

This Warren Buffett Bargain Stock Is Good For A Double

By Jonathan Poland Jonathan Poland 05-27-2015

CB&I Announces DPC Technology Award in China

By PRNewswire PRNewswire 04-03-2018

Seeking Value in the Construction Industry

By Mark Yu Mark Yu 07-03-2017

Dollar Cost Average on CBI

By Jonathan Poland Jonathan Poland 08-17-2017

CB&I Announces Novolen Technology Award in China

By PRNewswire PRNewswire 04-03-2018